Furthermore, in biopsies from CC and UC but not LC patients with active disease, increases in CTLA-4, PD-1, APRIL, BAFF, and IL-2Rα were seen compared with controls. This evidence concerns the gene TNFSF13B and laryngotracheoesophageal cleft.